Dr. Sajeve S. Thomas
Claim this profileOrlando Health Cancer Institute
About Sajeve S. Thomas
Education:
- Obtained MD from St. George's University School of Medicine in 2010.
- Completed Residency in Internal Medicine at the University of Florida College of Medicine – Jacksonville in 2013.
- Finished Fellowship in Hematology/Oncology at the University of Florida College of Medicine – Jacksonville in 2016.
Experience:
- Board-certified in Internal Medicine, Hematology, and Medical Oncology.
- Affiliated with Orlando Health Cancer Institute.
Area of expertise
Melanoma
Sajeve S. Thomas has run 11 trials for Melanoma. Some of their research focus areas include:
Skin Cancer
Sajeve S. Thomas has run 7 trials for Skin Cancer. Some of their research focus areas include:
Affiliated Hospitals
Orlando Health Cancer Institute
OrlandoHealth
Clinical Trials Sajeve S. Thomas is currently running
OBX-115
for Skin Cancer
This trial tests a new treatment called OBX-115 for adults with advanced solid tumors. It aims to see if the treatment is safe and effective by measuring its ability to shrink tumors, control disease progression, and improve survival.
Recruiting
1 award
Phase 1 & 2
11 criteria
Encorafenib/Binimetinib/Nivolumab vs Ipilimumab/Nivolumab
for Melanoma
This phase II trial compares the effect of encorafenib, binimetinib, and nivolumab versus ipilimumab and nivolumab in treating patients with BRAF- V600 mutant melanoma that has spread to the brain (brain metastases). Encorafenib and binimetinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Ipilimumab and nivolumab are monoclonal antibodies that may interfere with the ability of tumor cells to grow and spread. This trial aims to find out which approach is more effective in shrinking and controlling brain metastases from melanoma.
Recruiting
1 award
Phase 2
23 criteria
More about Sajeve S. Thomas
Clinical Trial Related
9 years of experience running clinical trials · Led 20 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Sajeve S. Thomas has experience with
- Pembrolizumab
- Nivolumab
- ADP-A2M4CD8
- IO102-IO103
- RP1
- Cemiplimab
Breakdown of trials Sajeve S. Thomas has run
Melanoma
Skin Cancer
Lung Cancer
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sajeve S. Thomas specialize in?
Sajeve S. Thomas focuses on Melanoma and Skin Cancer. In particular, much of their work with Melanoma has involved Stage IV patients, or patients who are Stage III.
Is Sajeve S. Thomas currently recruiting for clinical trials?
Yes, Sajeve S. Thomas is currently recruiting for 2 clinical trials in Orlando Florida. If you're interested in participating, you should apply.
Are there any treatments that Sajeve S. Thomas has studied deeply?
Yes, Sajeve S. Thomas has studied treatments such as Pembrolizumab, Nivolumab, ADP-A2M4CD8.
What is the best way to schedule an appointment with Sajeve S. Thomas?
Apply for one of the trials that Sajeve S. Thomas is conducting.
What is the office address of Sajeve S. Thomas?
The office of Sajeve S. Thomas is located at: Orlando Health Cancer Institute, Orlando, Florida 32806 United States. This is the address for their practice at the Orlando Health Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.